Zynerba gains after $42M IPO

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) jumped $2.25 (16%) to $16.25 in its first day of trading Wednesday after raising $42 million through the sale of 3 million shares at $14 in an IPO underwritten by Jefferies; Piper Jaffray; Canaccord; and Oppenheimer. The IPO valued the company at $122.3 million. Zynerba had filed in June to raise up to $57.5 million. ...